Panel Discussion

Saturday, November 18, 2023

10:45 AM - 11:45 AM MST

Panelist(s)

Esther Babady, PhD (she/her/hers)

Chief, Clinical Microbiology Service
MEMORIAL SLOAN KETTERING CANCER CENTER
New York, New York, United States
Jennifer Dien Bard, PhD

Director, Microbiology and Virology; Interim Chief of Laboratory Medicine; Professor of Pathology
Children's Hospital Los Angeles; University of Southern California
South Pasadena, California, United States
Alexander L. Greninger, MD, PhD, MS, MPhil

Associate Professor
University of Washington
Seattle, Washington, United States

Session Description: Utilization of clinical molecular diagnostic methods for detecting microbial pathogens continues to expand and, in some cases, supplant conventional identification methods in a variety of scenarios. The AMP Clinical Practice Committee's Infectious Diseases Multiplex Working Group with representation from ASM, IDSA, and PASCV conducted a review of the current benefits and challenges to using multiplex PCR for the detection of pathogens from gastrointestinal, central nervous system, lower respiratory tract, and joint specimens. Panel will discuss future directions and novel approaches to detection of pathogens in alternate specimen types, along with challenges associated with implementation of these multiplex PCR panels, will be discussed.

Presentation Topics: Brief presentation of manuscript
Panel discussion

Learning Objectives:

Identify current benefits and challenges to using multiplex PCR for detection of pathogens from gastrointestinal, central nervous system, lower respiratory tract, and joint specimens.
Identify future directions and novel approaches to detection of pathogens in alternate specimen types, and outlines challenges associated with implementation of these multiplex PCR panels.